Stevanato Group S.p.A. (STVN) Stock

Stevanato Group S.p.A. (STVN) is a Healthcare stock trading at $17.58 (as of 2026-06-18), with a market capitalization of $5.71B and a trailing P/E of 36.9. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Stevanato Group S.p.A. designs, manufactures, and supplies drug and healthcare-related products and processes, including containment solutions, drug delivery systems, medical devices, and related inspection, assembly, packaging, and glass-forming equipment. It provides integrated solutions for pharmaceutical and healthcare customers.

Valuation — source: SEC EDGAR (first-party)
Price$17.58
Market Cap$5.71B
P/E Ratio36.9
Price / Book3.84
Price / Sales4.81
DCF Value (model)$24.27
DCF Upside vs Price38.1%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$1.19B
Net Margin11.8%
Return on Equity9.4%
Current Ratio1.76
Revenue Growth (YoY)7.4%
EPS Growth (YoY)18.6%
Valuation vs Sector & Industry
Stock P/E36.9
Sector P/E (Healthcare)21.0
Industry P/E (Medical Equipment)31.7
vs Sector76.3%
vs Industry16.4%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderConestoga Capital Advisors, LLC ($116.76M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEOFranco Stevanato
Employees5,521
CountryIT
IPO Date2021-07-16

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Bruker Corporation (BRKR)
  • Masimo Corporation (MASI)
  • Glaukos Corporation (GKOS)
  • MSA Safety Incorporated (MSA)
  • Mirion Technologies, Inc. (MIR)
  • Bausch + Lomb Corporation (BLCO)
  • iRhythm Technologies, Inc. (IRTC)
  • Merit Medical Systems, Inc. (MMSI)
STVN earnings history · STVN institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.